No results for ‘’
Innova Captab Ltd
NSE: INNOVACAP BSE: 544067
₹973.25
(1.10%)
Fri, 24 Jul 2026, 01:48 pm
Market Cap (in Cr)5510.19
PE Ratio39.52
Dividend0.20
Health Technology
Pharmaceuticals: Major
24.5KInnova Captab Cashflow
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -106.68M | -99.70M | -55.86M | -75.03M | -110.77M | -159.57M | -247.79M |
| Accumulated depreciation, total | -404.93M | -504.63M | -157.57M | -235.42M | -318.14M | -460.38M | -683.83M |
| Cash from operating activities | 137.46M | 246.65M | 381.60M | 536.49M | 552.40M | 1.34B | 659.84M |
| Funds from operations | 312.30M | 394.80M | 392.99M | 749.20M | 863.00M | 1.27B | 1.81B |
| Net income (cash flow) | 191.82M | 258.63M | 345.00M | 639.53M | 679.54M | 943.45M | 1.28B |
| Depreciation & amortization (cash flow) | 106.68M | 99.70M | 55.86M | 75.03M | 110.77M | 159.57M | 247.79M |
| Depreciation/depletion | 106.68M | 99.70M | 53.33M | 73.13M | 109.17M | 157.62M | 245.72M |
| Amortization | — | — | 2.53M | 1.90M | 1.60M | 1.95M | 2.07M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -34.68M | -50.36M | -126.31M | -183.03M | -165.72M | -188.72M | -150.62M |
| Changes in working capital | -174.83M | -148.15M | -11.39M | -212.71M | -310.60M | 73.12M | -1.15B |
| Cash from investing activities | -90.81M | -49.46M | -197.43M | -1.89B | -913.14M | -5.01B | -1.55B |
| Capital expenditures | -86.40M | -40.99M | -187.31M | -798.83M | -789.91M | -2.87B | -1.72B |
| Capital expenditures - fixed assets | -86.40M | -40.99M | -187.31M | -798.83M | -789.91M | -2.87B | -1.72B |
| Capital expenditures - other assets | 0 | 0 | 0 | — | — | — | — |
| Cash from financing activities | -46.71M | -187.87M | -158.60M | 1.31B | 394.47M | 3.76B | 933.01M |
| Free cash flow | 51.07M | 205.65M | 194.29M | -262.34M | -237.51M | -1.53B | -1.07B |